Clinical Trial Update: Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating VNX001 against its lidocaine and heparin components or placebo in interstitial cystitis/bladder pain syndrome; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• Heparin (unfractionated heparin)
• Lidocaine (Lidocaine)
• VNX001

Snippet

Sponsor: Vaneltix Pharma, Inc. | Conditions: Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Status: RECRUITING